<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="11612">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01926106</url>
  </required_header>
  <id_info>
    <org_study_id>twins</org_study_id>
    <nct_id>NCT01926106</nct_id>
  </id_info>
  <brief_title>Nasal Intermittent Positive-Pressure Ventilation for Twin Infants With Respiratory Distress Syndrome</brief_title>
  <acronym>twins</acronym>
  <official_title>Nasal Intermittent Positive-Pressure Ventilation vs Nasal Continuous Positive Airway Pressure for Twin Infants With Respiratory Distress Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Daping Hospital and the Research Institute of Surgery of the Third Military Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Daping Hospital and the Research Institute of Surgery of the Third Military Medical University</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the present study, we hypothesized that primary mode nIPPV initiated shortly after birth
      would decrease the incidence of intubation or death in twin infants when compared to nCPAP.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After inclusion of eligible twins infants,one of the twins was supported by nCPAP and
      another nIPPV.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>incidence of intubation</measure>
    <time_frame>48h</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>incidence of BPD</measure>
    <time_frame>1 month</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>death</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">64</enrollment>
  <condition>Neonatal Respiratory Distress Syndrome</condition>
  <arm_group>
    <arm_group_label>nIPPV</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>the infants in the arm were supported by Nasal Intermittent Positive-Pressure Ventilation(nIPPV)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>nCPAP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>the infants in the arm were supported by Nasal Continuous Positive Airway Pressure(nCPAP)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>nIPPV</intervention_name>
    <description>one of the twins was randomly allocated to nIPPV</description>
    <arm_group_label>nIPPV</arm_group_label>
    <other_name>nIPPV:Nasal Intermittent Positive Pressure Ventilation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>nCPAP</intervention_name>
    <description>another of the twins was allocated to nCPAP</description>
    <arm_group_label>nCPAP</arm_group_label>
    <other_name>nCPAP:Nasal Continuous Positive Airway Pressure</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Twins

          -  Clinical diagnosis of mild-moderate respiratory distress syndrome

          -  requiring a fraction of inspired oxigen (FiO2 ) &lt;0.40 to keep oxygen saturation of
             90%-95%

          -  a chest X-ray suggestive of early stage hyaline membrane disease, (i.e. mild
             microgranulia  and air bronchogram)

        Exclusion Criteria:

          -  pneumothorax

          -  pneumomediastinum

          -  surgical diseases

          -  cardiac diseases

          -  intraventricular hemorrage

          -  major congenital defects
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>6 Hours</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Long Chen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Pediatrics, Daping Hospital, Research Institute of Surgery, Third Military Medical University,</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Long Chen, MD</last_name>
    <phone>8613883559467</phone>
    <email>neuroclong@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Pediatrics, Daping Hospital, Research Institute of Surgery, Third Military Medical University</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <zip>400042</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Long Chen, MD</last_name>
      <phone>8613883559467</phone>
      <email>neuroclong@126.com</email>
    </contact>
    <investigator>
      <last_name>Long Chen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>August 19, 2013</lastchanged_date>
  <firstreceived_date>August 8, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Daping Hospital and the Research Institute of Surgery of the Third Military Medical University</investigator_affiliation>
    <investigator_full_name>Chen Long,MD</investigator_full_name>
    <investigator_title>Prof;MD</investigator_title>
  </responsible_party>
  <keyword>Nasal Intermittent Positive-Pressure Ventilation</keyword>
  <keyword>Nasal Continuous Positive Airway Pressure</keyword>
  <keyword>twin</keyword>
  <keyword>respiratory distress syndrome</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Hyaline Membrane Disease</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
